Evaluation of new magnetic resonance imaging techniques
Evaluation of New Magnetic Resonance Techniques
This study is testing new MRI techniques on patients and healthy volunteers to see if they provide better images and measurements than the standard methods.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 2850 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Royal Marsden NHS Foundation Trust Academic / other |
| Locations | 1 site (Sutton, Surrey) |
| Trial ID | NCT05118555 on ClinicalTrials.gov |
What this trial studies
This research protocol aims to evaluate new and emerging magnetic resonance (MR) techniques in both patients and healthy volunteers after software or hardware upgrades. The study serves as a master protocol to assess multiple MR techniques, focusing on their feasibility, image quality, and measurement repeatability. By comparing these new approaches with standard procedures, the study seeks to identify promising techniques for further investigation or clinical adoption. Additional measurements will be performed during routine MR examinations without significant added risk or time.
Who should consider this trial
Good fit: Ideal candidates include patients undergoing routine clinical MR examinations who can provide verbal consent for additional data acquisition.
Not a fit: Patients who are claustrophobic or unwilling to undergo additional MR examinations may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the quality and effectiveness of magnetic resonance imaging, leading to better diagnostic outcomes for patients.
How similar studies have performed: Other studies have shown success in evaluating new imaging techniques, indicating that this approach has potential for meaningful advancements.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Type 1: Patients undergoing a routine clinical MR examination using established MR techniques to which an additional new sequence is added for evaluation, who give verbal consent for additional data to be acquired for evaluation of a new MR technique. * Type 2: Patients who voluntarily agree to participate in the study by giving written informed consent. * Type 3: Normal volunteers who voluntarily agree to participate in the study by giving written informed consent. Exclusion Criteria: * Standard MR Exclusion criteria apply to all MR examinations, as documented in the MRI Local Rules. * Patients or volunteers who are unwilling to undergo an additional MR examination, for example due to claustrophobia, will be excluded from the study. * Normal volunteers who do not have an NHS number or who are not registered with a GP will be excluded.
Where this trial is running
Sutton, Surrey
- The Royal Marsden NHS Foundation Trust — Sutton, Surrey, United Kingdom (Recruiting)
Study contacts
- Principal investigator: Dow-Mu Koh, MD,FRCP,FRCR — Royal Marsden NHS Foundation Trust
- Study coordinator: Bertha Adjei
- Email: Bertha.Adjei4@rmh.nhs.uk
- Phone: 0208 661 3728
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.